# FDA Inspection 1225617 - Janusz Jaworski, M.D., Ph.D - November 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/janusz-jaworski-md-phd/582daee4-9db7-4eff-a3c7-6db205517309
Source feed: FDA_Inspections

> FDA Inspection 1225617 for Janusz Jaworski, M.D., Ph.D on November 10, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225617
- Company Name: Janusz Jaworski, M.D., Ph.D
- Inspection Date: 2023-11-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1248412 - 2024-08-29](https://www.keypedia.com/records/fda_inspections/janusz-jaworski-md-phd/14d26615-faf9-42d1-82b0-8cf0ca2b6053)
- [FDA Inspection 918711 - 2015-02-13](https://www.keypedia.com/records/fda_inspections/janusz-jaworski-md-phd/830e6f13-f9b0-4154-b043-66c027980eae)

Company: https://www.keypedia.com/companies/janusz-jaworski-md-phd/c47241e7-2e3c-4f96-b108-e9f244ae2a8a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c